• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750CM26A
Device Problems Difficult to Remove (1528); Mechanical Jam (2983)
Patient Problems Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Perforation (2001); Injury (2348); Pericardial Effusion (3271)
Event Date 07/09/2020
Event Type  Injury  
Manufacturer Narrative
Udi number: (b)(6).Investigation is ongoing.
 
Event Description
As reported, during a transfemoral transcatheter aortic valve replacement (tavr) procedure with a  26mm sapien 3 ultra valve, prior to crossing, the patient¿s pressure dropped and was put on pump.  a tee noted an effusion and the effusion was drained successfully.There was a left ventricular (lv) bleeding due to a wire perforation.  upon removal of the delivery system, the valve was stuck and there was withdrawal difficulty.  a cut down was performed at the left femoral head to remove the system.  the patient left the room in stable condition.
 
Manufacturer Narrative
The delivery system was not returned to edwards lifesciences for evaluation.  in addition, no relevant imagery was provided for review.  due to unavailability of the device, engineering was unable to be perform any visual, functional, or dimensional analysis; therefore, a manufacturing nonconformance was unable to be determined.During the manufacturing process, the delivery system was visually inspected and tested several times.  inflation balloons are 100% inspected for any defects.  the flex shaft was 100% visually inspected for physical damage.100% distal to proximal visual inspection by both manufacturing and quality.Additionally, the work order underwent product verification testing.  all testing passed specification for lot release.  these inspections and tests during the manufacturing process support that it is unlikely that a non-conformance contributed to the reported complaint.A device history record (dhr) review was performed and revealed no manufacturing issues that may have contributed to the reported event.  a lot history review was performed and revealed no additional similar complaints for delivery system withdrawal difficulty.A review of the risk management documentation was performed and the reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaint for delivery system withdrawal difficulty valve through sheath was unable to be confirmed.  a review of dhr, lot history, manufacturing mitigations revealed no indication that a manufacturing non-conformance contributed to the complaint.A review of ifu/training materials revealed no deficiencies.Per report, ¿upon removal of the delivery system, the valve was stuck [despite the coaxial alignment between the delivery system and sheath tip], and there was withdrawal difficulty.A cut down was performed at the left femoral head to remove the system.¿ it is possible that the crimped valve was caught on the sheath tip during retrieval attempts, leading the user to withdraw the device down to femoral head without re-sheathing the crimped valve and then surgically remove the device.Patient factors such as calcification (if present) could impact the ability to retrieve the valve into the sheath.During system retrieval, the interaction between the crimped valve and calcification (if any) could distort the frame, leading to increase profile and higher chances for the valve being caught on the sheath tip.However, without patient anatomy information or applicable imagery, the suggested root cause could not be confirmed.There is insufficient information to determine a root cause at this time.Since no product non-conformances or ifu/training deficiencies were identified during evaluation, a product risk assessment escalation and a corrective/preventative actions are not required.
 
Manufacturer Narrative
Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key10362330
MDR Text Key202395897
Report Number2015691-2020-12918
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 07/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/02/2022
Device Model Number9750CM26A
Device Lot Number63118414
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-